FDA approves first AI tool to predict breast cancer risk

“Clairity’s FDA authorization is a turning point for more women to access the scientific advances of AI-driven cancer risk prediction,” Larry Norton, founding scientific director of the Breast Cancer Research Foundation, wrote in another statement. 

“Breast cancer is rising, especially among younger women, yet most risk models often miss those who will develop the disease,” he said. “Now we can ensure more women get the right care at the right time.”

“Advancements in AI and computer vision can uncover hidden clues in the mammograms,” stated the founder of Clairity. (iStock)

More than 2.3 million women are diagnosed with breast cancer globally each year, including more than 370,000 in the U.S., despite “decades of progress,” according to the Breast Cancer Research Foundation.

Cases have particularly been on the rise among younger women under the age of 50.

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

In a Tuesday appearance on “America’s Newsroom,” Fox News senior medical analyst Dr. Marc Siegel called Clairity’s development “profound.”

“Just looking at a mammogram … sometimes [radiologists] will see things that aren’t clear, they have to follow it over time,” he said. “AI improves how focused and how predictive it is, [shown] very dramatically in studies.”

Younger women are being diagnosed with breast cancer more frequently, data shows. (iStock)

Siegel confirmed that radiologists across the country are generally in support of leveraging AI for cancer detection, especially in areas of the country that are “underserved” in terms of healthcare.

For more Health articles, visit www.foxnews.com/health

“In areas where you’re relying on radiologists without special training, this is even more important,” he said. 

“This is the wave of the future. AI is going to be part of the equation, but it’s not going to take over.”